Reproducibility and Method Comparison of the Quo-Test™ A1C System and the Quo-Lab A1C Test and CLIA Waiver of the Quo-Test™ A1C System
The Quo-Test A1C Analyzer and Reagent Test System (Quo-Test A1C System) are intended for the in-vitro quantitative determination of glycated hemoglobin in whole blood samples obtained from fingerstick or venous samples for point-of-care testing. The Quo-Test A1C System is indicated in the management and treatment of diabetes and for monitoring long term glycemic control by diabetics. It is for multiple patient use. Only auto-disabling, single use lancing devices should be used with this system.
100 项与 Quotient Diagnostics Ltd. 相关的临床结果
0 项与 Quotient Diagnostics Ltd. 相关的专利(医药)
100 项与 Quotient Diagnostics Ltd. 相关的药物交易
100 项与 Quotient Diagnostics Ltd. 相关的转化医学